Generics - Biotechnology

Filter

Current filters:

Biotechnology

Popular Filters

1 to 25 of 108 results

10 billion real to be invested in Brazil’s production of biotech drugs by 2016

10 billion real to be invested in Brazil’s production of biotech drugs by 2016

27-01-2014

Brazil's Development Bank (BNDS) plans to invest up to 10 billion real ($4.2 billion) in the production…

BiotechnologyBrazilFinancialGenericsHypermarcasMarkets & MarketingProductionSanofiSouth America

EGA welcomes first biosimilar MAb approvals in Europe

12-09-2013

Following the European Medicines Agency's CHMP recommendation, the European Commission (EC) has just…

Anti-Arthritics/RheumaticsBiotechnologyGenericsPricingRegulation

First biosimilar monoclonal antibody approved in Europe

10-09-2013

US injectables and infusion technologies firm Hospira (NYSE: HSP) says the European Commission has approved…

Anti-Arthritics/RheumaticsBiotechnologyCellTrionEuropeGenericsHospiraInflectraMerck & CoRemicadeResearch

Final approval for California's SB 598 Biosimilars Bill

05-09-2013

A bill updating US State of California's pharmacy substitution law to allow greater patient access to…

BiotechnologyGenericsLegalNorth AmericaRegulation

Baxter and Coherus in up to $246 million deal for biosimilar etanercept

04-09-2013

US companies Baxter International (NYSE:BAX) and Coherus Biosciences have entered into an exclusive collaboration…

AmgenAnti-Arthritics/RheumaticsBaxter InternationalBiotechnologyCoherus BioSciencesEnbreletanerceptGenericsLicensingResearch

Phase III data support biosimilarity of BOW-015 to Remicade

29-08-2013

Privately-held US biotech firm EPIRUS Biopharmaceuticals, which is focused on the development and production…

Anti-Arthritics/RheumaticsBiotechnologyEPIRUS BiopharmaceuticalsGenericsinfliximabRegulationRemicadeResearch

California Assembly passes controversial biosimilars bill

29-08-2013

In the USA this week, the California Assembly has passes legislation that would allow pharmacists to…

BiotechnologyGenericsLegalNorth AmericaPoliticsRegulation

Biocad enters deal for exporting rituximab biosimilar to Turkey

22-08-2013

Biocad, one of Russia's leading biotechnology companies, has signed a definitive agreement on the export…

BiocadBiotechnologyEuropeGenericsKocak FarmaLicensingMabTheraMarkets & MarketingOncologyRituxanrituximabRoche

US firms establish strategic partnership around biosimilars

06-08-2013

Privately-held Oncobiologics has formed a broad strategic partnership with fellow USA-based inVentiv…

AvastinBiotechnologyErbituxGenericsHerceptinHumiraImmunologicalsinVentive HealthOncobiologicsOncologyProductionResearchRituxan

Pharma associations strongly support Senate bill on FDA User Fees sequestration exemptions

05-08-2013

In the USA last week, Mark Pryor (Democrat, Arkansas), chairman of the Senate Appropriations Subcommittee…

BiotechnologyFinancialGenericsLegalNorth AmericaPharmaceuticalPolitics

US payers have more faith in biosimilars from multinationals

22-07-2013

US payer's trust in specific biosimilar manufacturers could dictate which companies will be most successful…

BiotechnologyEuropeGenericsNorth AmericaProductionRegulation

EMA's CHMP backs approval of first two monoclonal antibody biosimilars of blockbuster Remicade

29-06-2013

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended…

Anti-Arthritics/RheumaticsBiotechnologyCellTrionEuropeGenericsHospiraInflectraMerck & CoRegulationRemsima

Sandoz initiates Ph III trial for biosimilar Enbrel

24-06-2013

Swiss drug major Novartis' (NOVN: VX) generics unit Sandoz has initiated a major Phase III clinical trial…

AmgenAnti-Arthritics/RheumaticsBiotechnologyDermatologicalsEnbrelGenericsNovartisResearchSandoz

Increased focus on generics and biosimilars only way to make European health care sustainable, says EGA

13-06-2013

Addressing delegates at the 19th European Generic medicines Association (EGA) Annual Conference in Athens,…

BiotechnologyEuropeFinancialGenericsHealthcareRegulation

EMA initiates consultation on guideline on biosimilars containing biotechnology-derived proteins

10-06-2013

The European Medicines Agency today (June 10) released a revision of the guideline addressing the clinical…

BiotechnologyEuropeGenericsRegulation

New Florida law takes a major step in promoting access to biologic medicines

06-06-2013

Legislation amending the US state of Florida's existing prescription drug substitution law has the potential…

BiotechnologyGenericsLegalMarkets & MarketingNorth AmericaRegulation

Hospira's biosimilar epoetin meets primary endpoints in post-marketing study

04-06-2013

Leading provider of injectable drugs and infusion technologies Hospira (NYSE: HSP) says that results…

BiotechnologyepoetinGenericsOncologyResearchRetacrit

US Senate confirms appointment of Marilyn Tavenner as CMS Administrator

16-05-2013

US Health and Human Services (HHS) Secretary Kathleen Sebelius announced that the US Senate has confirmed…

BiotechnologyGenericsHealthcareManagementNorth AmericaPharmaceutical

Cancer treatments "unaffordable" and will drive rapid transition to generics and market decline, says GlobalData

10-05-2013

The rising prices of new cancer drugs are resulting in an increasing cost burden for patients and health…

BiotechnologyGenericsGlobalMarkets & MarketingOncologyPharmaceuticalPricing

Florida joins growing list of US states blocking some Biosimilars Bills provisions

08-05-2013

Last Friday, the US state of Florida joined several states, most recently Indiana, in refusing to enact…

BiotechnologyGenericsLegalNorth AmericaRegulation

Global biosimilar drug revenues will reach $2,445 million in 2013, says Visiongain

08-05-2013

The world market for biosimilar drugs will be worth $2,445 million in 2013, growing by more than 20%…

BiotechnologyCellTrionGenericsGlobalHospiraMarkets & MarketingSandoz

EU member states urged to boost biosimilars market access

26-04-2013

"Safe and effective biosimilar monoclonal antibodies will arrive soon," announced Gudbjorg Edda Eggertsdottir,…

BiotechnologyEuropeGenericsRegulation

1 to 25 of 108 results

Back to top